IRIS
CASTIGLIONE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.175
EU - Europa 1.056
AS - Asia 341
SA - Sud America 7
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.136
IT - Italia 522
SG - Singapore 175
GB - Regno Unito 148
IE - Irlanda 126
DE - Germania 78
CN - Cina 62
FI - Finlandia 58
UA - Ucraina 46
CA - Canada 37
VN - Vietnam 36
HK - Hong Kong 26
SE - Svezia 24
PK - Pakistan 20
IN - India 14
RO - Romania 13
FR - Francia 12
AT - Austria 10
AU - Australia 4
ES - Italia 4
NL - Olanda 4
AR - Argentina 3
BD - Bangladesh 3
HU - Ungheria 3
IR - Iran 3
CH - Svizzera 2
DK - Danimarca 2
MG - Madagascar 2
PE - Perù 2
BR - Brasile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
IL - Israele 1
LT - Lituania 1
MX - Messico 1
PL - Polonia 1
RS - Serbia 1
TR - Turchia 1
Totale 2.586
Salva come PNG Salva come JPEG
Città #
Chandler 181
Singapore 136
Dublin 126
Boardman 104
Fairfield 84
San Mateo 82
Cambridge 61
Pisa 61
Rome 55
Helsinki 42
Wilmington 40
Seattle 38
Stevenage 38
Portsmouth 36
Ottawa 34
Florence 33
Southend 33
Falls Church 32
Ashburn 30
Lawrence 30
Woodbridge 29
Santa Clara 28
Houston 26
Jacksonville 24
Milan 23
Beijing 19
Munich 19
Dong Ket 18
Hong Kong 17
Lappeenranta 16
Livorno 16
Los Angeles 15
Washington 15
Ann Arbor 14
Buti 14
London 14
San Diego 14
Redmond 13
Assago 12
Genoa 12
Dearborn 11
Fremont 11
Bologna 10
Dallas 10
Islamabad 9
Norwalk 9
Palermo 9
Padova 8
Shanghai 8
West Jordan 8
Bari 7
Bucharest 7
Cascina 7
Central District 7
Lucca 6
Zirl 6
Guangzhou 5
Hounslow 5
Hyderabad 5
Iowa City 5
Nuremberg 5
Redwood City 5
Sector 3 5
Turin 5
Acton 4
Albavilla 4
Amsterdam 4
Berlin 4
Brooklyn 4
Frankfurt am Main 4
Gurugram 4
Lahore 4
Melbourne 4
Naples 4
Viareggio 4
Vienna 4
Agordo 3
Birmingham 3
Concordia 3
Custonaci 3
Forlì 3
Mola di Bari 3
Nanjing 3
Oristano 3
Parma 3
Peshawar 3
Serra 3
Shenzhen 3
Varallo Pombia 3
Veresegyház 3
Verona 3
Azzano San Paolo 2
Barletta 2
Bengaluru 2
Brescia 2
Canzo 2
Castelnuovo di Val di Cecina 2
Catania 2
Chicago 2
Chiswick 2
Totale 1.918
Salva come PNG Salva come JPEG
Nome #
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 125
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 124
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 99
A simple echocardiographic score to rule out cardiac amyloidosis 98
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 89
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 81
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 80
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 73
Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction 72
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 70
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 68
Treatment of cardiac transthyretin amyloidosis: an update 60
Biomarkers for the diagnosis and management of heart failure 60
Atrial amyloidosis: mechanisms and clinical manifestations 55
Use of biomarkers to diagnose and manage cardiac amyloidosis 54
Cardiovascular disease and COVID-19: les liaisons dangereuses 52
Biomarkers for the diagnosis and management of heart failure: New frontiers 52
Molecular autopsy of sudden cardiac death in the genomics era 52
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 50
Role of Imaging in Cardiomyopathies 49
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 45
Current and emerging drug targets in heart failure treatment 45
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 44
Cardiac magnetic resonance in patients with muscular dystrophies 41
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets 39
A simple echocardiographic score to rule out cardiac amyloidosis 37
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week 36
Coronary Artery Anomalies 35
The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis? 33
The unbearable underreporting of comorbidities in heart failure clinical trials 32
sST2 for Outcome Prediction in Acute Heart Failure: Which Is the Best Cutoff? 32
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 32
Safety and Efficacy of Amiodarone in a Patient With COVID-19 32
Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis 31
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 31
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 30
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 30
What Is Hidden Behind Inferior Negative T Waves: Multiple Cardiac Glomangiomas 27
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 25
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction 25
[Central apneas and cardiovascular diseases] 24
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis 23
Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’ 23
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 22
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is 22
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 22
Valve disease in cardiac amyloidosis: an echocardiographic score 20
Stroke in ATTR cardiac amyloidosis: Does only rhythm matter? 19
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 19
Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry 18
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 18
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy 17
Sex differences in transthyretin cardiac amyloidosis 16
Cardiovascular toxicity from therapies for light chain amyloidosis 16
RNA-targeting and gene editing therapies for transthyretin amyloidosis 15
Valvular heart disease in patients with cardiac amyloidosis 15
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 14
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis 14
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 13
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction 12
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 12
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 12
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 11
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 11
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 11
Eligibility for vericiguat in a real‐world, contemporary heart failure population 10
Critical Reading of cardiovascular trials with neutral or negative results 9
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 9
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 9
Tissue Characterization in Cardiac Amyloidosis 8
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond 8
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 8
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction 7
Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines 7
Targeting precipitants to prevent heart failure hospitalization. Does season matter? 6
Disease features and management of cardiomyopathies in women 6
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 5
Pathophysiology of Cardiac Amyloidosis 4
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 4
Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician 3
Do we need to EVALUATE multiple biomarkers and/or the same biomarkers multiple times in patients with heart failure? 3
Statin therapy in COVID-19 infection 3
Totale 2.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202093 0 0 2 4 8 14 11 11 14 12 3 14
2020/2021344 26 28 17 27 13 26 22 24 39 24 49 49
2021/2022544 45 67 17 39 25 62 45 94 58 50 7 35
2022/2023563 33 61 23 50 58 71 23 49 103 22 51 19
2023/2024756 43 15 140 74 47 65 53 31 27 47 31 183
2024/2025354 51 97 206 0 0 0 0 0 0 0 0 0
Totale 2.673